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ABSTRACT
Supramolecular proteins are generated using a limited set of twenty amino acids, but have distinctive 
functionalities which arise from the sequential arrangement of amino acids configured to exquisite three-
dimensional structures. Viruses, virus-like particles, ferritins, enzyme complexes, cellular micro-compartments, 
and other supramolecular protein assemblies exemplify these systems, with their precise arrangements of tens 
to hundreds of molecules into highly organized scaffolds for nucleic acid packaging, metal storage, catalysis 
or sequestering reactions at the nanometer scale. These versatile protein systems, dubbed as bionanoparticles 
(BNPs), have attracted materials scientists to seek new opportunities with these pre-fabricated templates in a 
wide range of nanotechnology-related applications. Here, we focus on some of the key modifi cation strategies 
that have been utilized, ranging from basic protein conjugation techniques to more novel strategies, to expand 
the functionalities of these multimeric protein assemblies. Ultimately, in combination with molecular cloning 
and sophisticated chemistries, these BNPs are being incorporated into many applications ranging from 
functional materials to novel biomedical drug designs.
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Introduction
Biological materials have been extensively utilized as 
starting precursors to generate ornate nanostructures 
for materials development [1 7]. For example, the 
fi nite number of building blocks and established base-
pairing rules in nucleic acids provides a predictable 
system that has been used to design two- and three-
dimensional lattices [8 10], geometrical shapes [11, 
12], and other nanopatterns [13, 14]. Nature also 
employs protein assemblies, such as viruses and 
virus-like particles (VLPs) [15], ferritins [16, 17], heat 
shock protein cages [18], and enzyme complexes [19
21] to form robust biosynthetic machineries (Fig. 1). 
These protein shells, or bionanoparticles (BNPs), are 
highly organized nanoscale materials with robust 
chemical and physical properties while still being 
capable of modification by genetic and chemical 
methods. A myriad of viruses and VLPs have been 
genetically and chemically reprogrammed to function 
as drug/gene delivery vehicles [22 24], vaccines [25
27], and nanomaterials [28 34]. 
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In comparison to conventional synthetic particles, 
viruses and viral-like protein assemblies are 
attractive for the development of new materials for 
the following reasons:  
(1) They represent very stable and beautiful self-
assembled architectures at the nanometer level 
with sizes ranging from 10 nm to 200 nm, which 
are otherwise very difficult to make by standard 
synthetic methods in the laboratory.
(2 )  Three-dimensional  s t ructures  can  be 
characterized at near atomic resolution.
(3) The composition and surface properties of the 
viruses can be controlled using molecular biology.
(4) They can be purifi ed inexpensively on a large 
scale, a crucial advantage when considered for 
materials development.
(5) For each type of virus and virus-like protein 
assembly, all the particles are identical. We can 
therefore envision them as truly mono-disperse 
nanoparticles. 
Recently, there have been quite a few detailed 
review articles which summarize the application 
of viruses or viral protein cages in biomedicine 
and materials science [35 39]. In this review, we 
highlight some of the general approaches utilized 
to modify these viruses, ferritins, and other protein 
assemblies in order to impart novel functionalities for 
nanotechnology applications. 
 
1.1    Chemically addressable bionanoparticles
Many of the basic protein conjugation schemes 
permeate fundamental BNP chemistry, targeting 
endogenous amino acids, such as lysines, glutamic 
or aspartic acids, and cysteines. Less commonly 
targeted functional groups, such as the phenol ring 
of tyrosines, have also been incorporated into this 
approach (Fig. 2). The systematic characterization 
of cowpea mosaic virus (CPMV) [40 44], along with 
studies of cowpea chlorotic mottle virus (CCMV) 
[45], bacteriophage MS2 [46], heat shock protein [18], 
tobacco mosaic virus (TMV) [47], and turnip yellow 
mosaic virus (TYMV) [48], have shed light on the 
unique chemical reactivities and physical properties 
of these individual BNPs. These initial discoveries 
have been integred to design BNPs as nano-scaffolds 
for drug delivery, bioimaging, biomineralization, and 
even tissue engineering. 
For instance, based on the crystal structure of 
CPMV (Fig. 3(a)) [49], only a few lysine residues 
per  asymmetric  unit  appear  exposed to the 
solvent (Fig. 3(b)), whereas the majority of the 
lysine groups are found buried or interacting with 
neighboring residues (Fig. 3(c)). Studies indicated 
that reactions with N-hydroxysuccinimide (NHS) 
ester-functionalized fluorescein dyes preferentially 
targeted these surface-exposed lysines [41, 50]. 
Figure 1    Three-dimensional structures of bionanoparticles: moving 
clockwise from the top are ferritin, heat shock protein, lumazine 
synthase, brome mosaic virus, MS2 bacteriophage, cowpea chlorotic 
mosaic virus, turnip yellow mosaic virus, cowpea mosaic virus and 
in the center, tobacco mosaic virus. Models were generated using 
PyMol (www.pymol.org) with coordinates obtained from the RCSB 
Protein Data Bank (www.pdb.org)
Figure 2    Conventional protein conjugation strategies targeting the 
endogenous amino acids (lysine, cysteine, aspartic or glutamic acids, 
and tyrosine) on bionanoparticles
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Johnson and colleagues characterized the relative 
reactivity of the fi ve lysines by sequentially replacing 
each residue with arginines, and found that each 
lysine possessed varying reactivities and no single 
lysine residue accounted for all of the reactivity of 
the virus [50]. The authors suggest that each lysine 
being housed in different microenvironments would 
account for the varied reactivity of the different 
residues. A chemical reactivity study of TYMV 
showed that lysine at position 32 had significant 
reactivity towards fluorescein NHS esters, whereas 
other lysines in various locations were less reactive. 
According to its structural data, TYMV protrudes a 
fl exible N-terminal region housing the reactive lysine, 
K32, thus presenting that particular amino group 
in a more solvent-accessible state than the other 
lysines [51]. In one particular insect virus, Nudaurelia 
capensis ω virus, the particles undergo a pH-induced 
structural shift, shrinking in size with decreasing pH. 
The virus, as predicted, exhibited varied chemical 
reactivity based on its different conformations, 
with the larger, more porous state having more 
chemical conjugates than the smaller, less permeable 
confi guration [52]. 
Similar variations in reactivity are also observed with 
other endogenous residues. The exposed carboxylic 
groups of BNPs have been demonstrated to undergo 
selective modification upon activation by using a 
co-catalysis system, 1-(3-dimethylaminopropyl-3-
ethylcarbodiimide) hydrochloride (EDC) and NHS. 
These reagents have been previously used in the 
derivatization of carboxylic groups of ferritins with 
long chain aliphatic amines, resulting in stable, 
hydrophobic macromolecules [53, 54]. In recent 
years, systematic characterizations implemented 
with EDC coupling reactions have been conducted 
on various plant viruses (CPMV, TYMV, CCMV, 
and TMV) [45, 47, 48, 55]. Schlick and co-authors 
reported efficient coupling via EDC in the presence 
of 1-hydroxybenzotriazole (HOBT) [47]. Their 
study indicated that the activation of carboxylate 
groups on TMV was restricted to the glutamic acid 
residues exposed to the inner channel surface with 
no detectable attachments to the exterior surface. 
Studies with TYMV [51], CPMV [55], and CCMV [45] 
also revealed several carboxylate groups, which were 
solvent-accessible, and capable of being modified 
with small molecules.
In the case of tyrosine, the electron donating 
effect of the hydroxyl group makes the phenol 
group suscept ible  towards  an e lectrophi l ic 
attack at the ortho-position to the OH group. 
Using diazonium salts (Ar N N+), tyrosine can 
be selectively functionalized with relative ease 
[56]. This reaction has been applied to selectively 
modify the surface tyrosines on TMV and MS2 
[46, 47]. However, the reactivity is diminished 
when diazonium reagents without an electron 
withdrawing group on the aromatic rings are used. 
To circumvent this shortcoming, Francis and co-
workers further improved the reaction by sequential 
derivations in order to render the tyrosine more 
susceptible to sophisticated modifications [57, 
58]. A nitro-substituted diazonium salt afforded 
Figure 3   (a) Ribbon model diagram of cowpea mosaic virus with the pentameric unit highlighted in red; (b) surface exposed lysines along 
the five-fold axis highlighted in color (K182 in red, K138 in blue, K299 in green, K2199 in orange, and K234 in purple); (c) according to 
crystallographic data, the red spheres are lysines found to be inaccessible to small molecule reactions. Images are rendered with PyMol with 
coordinates obtained from the RCSB Protein Data Bank
(a) (b) (c)
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excellent modification of tyrosine residues located 
inside the bacteriophage MS2, enhancing its use 
for storage of drugs and as an MRI contrast agent 
[57 59]. This protocol has been expanded with a 
larger pool of reagents and reaction conditions for 
TMV, demonstrating this method to be a flexible 
and orthogonal procedure for BNP modification at 
tyrosines (Fig. 4).
1.2 Chemical modification in combination with 
genetic mutation
Surprisingly, no reactive cysteine residues are 
exposed on the exterior surface of most BNPs, a 
reasonable assumption being that evolution has 
disfavored particles forming inter-particle cross-
links via disulfide bonds. This presents the unique 
opportunity to genetically position the cysteine 
residue on strategic locations of viruses and protein 
shells, after which the sulfhydryl group can be 
selectively targeted with thiol-selective reagents. For 
instance, the virus coat protein of CPMV expresses 
14 cysteine residues (3 in the small subunit and 11 
in the large subunit); however, treatment of wild-
type CPMV with thiol-selective reagents yielded 
little or no attachments to the virus [42, 44]. Lin and 
collaborators have engineered the cysteine residue on 
surface-exposed loops based on several design criteria 
[60]. The mutants expressed the cysteine residue as 
part of an added small loop or as a point mutation 
(Fig. 5(a)), resulting in 60 copies of the inserted thiol 
being displayed symmetrically around the 30-nm-
diameter particle (Fig. 5(b)). Compared to the native 
virus, the new inserted cysteines demonstrated 
higher reactivity, with nearly all of the inserted 
thiol groups being chemically modified at very low 
concentration of a maleimide electrophile at neutral 
pH (Fig. 5(c)) [40]. Biologically-relevant proteins 
(T4 lysozyme, Her2, and LRR domain of internalin) 
could be anchored through the use of a bifunctional 
linker to the surface of an icosahedral virus via the 
engineered cysteine residue, meanwhile retaining the 
structural and biological functionalities of the virus 
and its conjugates [61]. The innate structural features 
of the virus have also been exploited to pattern 
gold nanoparticles around the three-dimensional 
space [62]. In another system, the heat shock protein 
from Methanococcus jannaschii (MjHsp) has been 
engineered with a cysteine residue housed within 
the interior and by coupling the reactivity of the 
cysteine with a pH-sensitive maleimide derivative, 
an antitumor drug was linked to the interior surface 
and selectively released upon decrease in pH [63]. 
Culver et al. designed and functionalized cysteine 
substituted-TMV particles with fluorescent dyes, 
and the modifi ed TMV particles were then partially 
disassembled to expose the single-stranded viral 
Figure 4    Scheme of tyrosine modifi cation in bacteriophage MS2 using various diazonium salts
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RNA. The exposed ssRNA strand was then utilized 
to hybridize to complementary DNA sequences 
patterned on surfaces [64, 65]. Francis and co-workers 
expressed TMV coat protein in a bacterial system 
to generate cysteine substituted-TMV coat proteins, 
which were modifi ed with fl uorescent chromophores 
for the purpose of generating a light-harvesting 
system. By controlling the pH and ionic strength, the 
proteins self-assembled into long fibrous structures 
which were capable of positioning the chromophores 
for effi cient energy transfer [66]. 
These studies highlight an important feature of 
BNPs, namely that chemically reactive groups can 
be genetically engineered to selectively position 
drug molecules, imaging agents, and biologically 
relevant molecules on the three-dimensional 
template, which is extremely diffi cult to realize using 
synthetic nanoparticles. In particular, the regio-
precision of surface functionalization can be crucial 
for many biomedical applications. For example, 
in their recent endeavor, the Finn group exploited 
the architectural features of the virus to explore 
how spatial distribution and polyvalent display 
of antigenic carbohydrates would modulate the 
mammalian immune response [67]. Moreover, a new 
way to enhance carbohydrate immunogenicity has 
been reported by means of ordered display on the 
surface of the CPMV capsid [68, 69]. In another study, 
murine polyoma VLPs genetically engineered with 
eight glutamic acids and one cysteine residue in one 
of its exterior loops tethered the anti-tumor antibody 
B3 via electrostatic interactions [70]. The antibody 
fragment was modified at the C-terminus with a 
peptide sequence (Arg8CysPro), which associates 
with the mutant VLP, and the complex is further 
stabilized by the formation of a disulfi de linkage. This 
coupling reaction yielded polyoma VLPs with 30 40 
antibody fragments bound to the surface, allowing 
the modifi ed VLPs to bind to breast carcinoma cells 
with high effi ciencies [70].
1.3    Novel bioconjugation techniques
Not all proteins are created equal, ergo all BNP 
scaffolds do not exhibit similar reactivities or 
selectivity. The need for selective reactions in complex 
biomolecules such as BNPs creates a new challenge 
to design alternative schemes to covalently modify 
proteins in aqueous or physiological solutions, 
while retaining their original structural integrity 
and functionality. Reactions such as Cu(I)-catalyzed 
azide-alkyne cycloaddition (CuAAC) [71] and other 
examples of transition metal catalysis [72] have 
addressed this need by successfully demonstrating 
cell-surface labeling and virus modifi cations. 
The CuAAC reaction, a member of the family of 
click reactions, has emerged as an excellent tool to 
Figure 5   (a) Cysteine residues engineered on CPMV on the protruding loop (βB βC), shown here in red, which have a tendency to aggregate 
without the presence of reducing agents. The lesser exposed loop (βE βF), shown in green, is more resistant to aggregation. (b) Each mutation 
resulted in 60 reactive thiol groups positioned around a predictable 3-D space, with a 28 Å spacing between each thiol group on the βB βC (red) 
loop versus a 50 Å spacing on the βE βF (green) loop. (c) The electron density difference after modifi cation with gold nanoparticles, shown in 
gold, clearly shows the attachment site is at the cysteine. Copyright Wiley-VCH Verlag GmbH & Co. KGaA. Reprinted with permission
(a) (b) (c)
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covalently fuse two different biological molecules 
together with relative ease [71, 73]. The exclusive 
reactivity and selectivity of both azido-and alkyne 
groups have placed this reaction among the favorites 
for protein coupling reactions due to its mild reaction 
conditions and high reaction rates. Although the 
presence of Cu(I) as a catalyst often interferes 
with proteins, the addition of a co-catalyst can 
dramatically enhance the reaction and quantitative 
amounts of modifi ed proteins are recovered after the 
reaction. In the presence of bipyridine derivatives, 
one class of new co-catalysts [74], the efficiency of 
the reaction has been signifi cantly improved so that 
micromolar concentrations of virus can be covalently 
attached with mid-micromolar concentrations of small 
molecules, polymers, and proteins, all with excellent 
purity and yield [75]. Over past few years, this 
reaction has been expanded to conjugate various small 
molecules and cell-targeting moieties onto viruses. The 
azide or alkyne moiety, after being attached to lysine, 
cysteine or tyrosine residues using conventional 
conjugation chemistry, can be rapidly reacted with 
high efficiency when only milli- to micromolar 
concentrations of valuable reagents are present 
[76]. The sequentially derivatized BNPs were then 
conjugated with fl uorogenic dyes, peptides, proteins, 
polyethylene glycol (PEG) polymers and complex 
carbohydrates [67, 75 80] (Fig. 6). The Finn group 
has further broadened this modification strategy by 
directly incorporating an azido-containing non-natural 
amino acid at the interior surface of the bacteriophage 
Qβ, positioning a chemically unique site within the 
virus [79]. 
Many bioconjugation pathways have been 
recently elaborated, opening new opportunities 
to selectively modify BNPs. For instance, selective 
alkylation of phenol groups in tyrosine residues has 
been achieved using π-allylpalladium complexes [81] 
in protein concentration levels as low as 5 μmol/L. 
Chymotrypsin A and bacteriophage MS2 displaying 
surface-exposed tyrosines were selectively modifi ed, 
whereas proteins lacking exposed tyrosines, even in 
the presence of a reactive cysteine residue, were not 
modified. Finn and colleagues approached tyrosine 
modification by using the tripeptide (Gly-Gly-His) 
in the presence of nickel acetate and magnesium 
monoperoxyphthalate to generate a tyrosyl radical 
[82]. In both reaction strategies, the authors suggested 
that the hydrophobic, aromatic ring interactions with 
the transition metal catalysts enhanced the selectivity 
towards tyrosine residues.
1.4    Multifunctional bionanoparticles for in vivo 
imaging and drug delivery
A new direction in biopharmaceuticals has been to 
design multifunctional scaffolds that contain imaging 
Figure 6    The CuAAC reaction permits sequential modifi cation of bionanoparticles with a universal handle, demonstrated in this fi gure using 
an alkyne-derivatized functional group
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agents, cell targeting, and therapeutic drugs to reduce 
non-specifi c cargo release and side-effects in patients. 
Combinations of the aforementioned bioconjugation 
strategies have been utilized to afford additional 
handles on BNPs, which should eventually lead to 
such multi-functional constructs. Therefore, both 
signaling moieties (like fluorescent or magnetic 
molecules) and biological recognition motifs (such 
as antibodies, oligonucleotides, ligands, receptors, 
or chemical sensors) can be simultaneously attached 
to BNPs, leading to possible nanosized vehicles for 
biosensing or drug delivery. 
For example, a CPMV mutant, expressing the 
uniquely reactive cysteine residue between residues 
G98 and K99 of the large subunit, still possesses all of 
the natural chemical reactivity of the exposed lysine, 
K38 [43, 50]. Therefore, one can sequentially modify 
the lysines with an NHS-ester (or isothiocyante) 
functionalized group and the cysteines with a 
maleimide group [43]. In one case, the CPMV 
mutant was functionalized with fluorescent dyes 
and immunoglobulin (chicken or mouse IgGs) to 
test its potential use in immunoassays (Fig. 7(a)) 
[83]. It has also been shown that fl uorescent dyes can 
be anchored on CPMV with controlled separation, 
which prevented the formation of non-fluorescent 
dimers and subsequent quenching, and thus afforded 
highly fl uorescent viral nanoparticles [84]. Such kind 
Figure 7    (a) Bifunctional CPMV displaying fl uorescent dye and immunoglobulin for immunoassays; (b) integrin targeting peptide sequence 
(Arg-Gly-Asp) engineered on a heat shock protein as a potential drug delivery agent to target melanomas; (c) terbium ligand complex 
conjugated to TYMV to generate time-resolved fl uoroimmuno assays
(a) (b)
(c)
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of engineered viral particles can be used as probes in 
microarray-based genotyping assays and sandwich 
immunoassays with improved sensitivities [83, 84]. 
Francis and co-workers generated doubly 
labeled TMV and MS2 by utilizing intrinsic amino 
acids to functionalize the exterior and the interior 
with small molecules, dyes, and polymers [47, 57]. 
Douglas, Young, and co-workers generated MjHsp 
with cysteines engineered in the interior of the shell 
and the cell targeting moieties on the exterior to 
direct the protein shell to melanomas (Fig. 7(b)) [85]. 
Wang and group recently generated TYMV labeled 
with a terbium complex and biotin as a prototype 
BNP for time-resolved fluoroimmuno assays (Fig. 
7(c)) [48], whilst Culver and co-workers have 
recently developed an elegant approach to assemble 
multifunctional TMV onto a solid substrate [65]. 
In addition to genetic modification of the surface 
protein to afford a reactive cysteine residue that was 
labeled with fluorescent markers, the particle was 
treated with an alkaline solution in order to remove 
~20 coat protein subunits from the virus 5’-end, 
exposing ~60 nucleotides. Such kind of particles 
can be further annealed with complementary DNA 
printed on a patterned microarray platform [64]. 
Using this strategy, Yi and co-workers prepared 
encoded microparticles via nucleic acid hybridization 
with mutant TMVs, which were suggested to have 
broad applications in multiplexed target sensing [86]. 
Notably, all of the doubly-modifi ed BNP scaffolds 
consistently retained their structural integrity 
throughout the reactions, which often involved a 
mixture of aqueous and organic solvents. Further 
studies of these BNPs are likely to involve in vitro 
and in vivo models of cellular targeting, uptake and 
drug delivery, but the anticipated immunogenic 
response will be a major obstacle to overcome for 
all protein-based scaffolds. To address this potential 
problem, Manchester and co-workers employed 
the CuAAC reaction to conjugate the folic acid-
PEG ligand to a mutant CPMV. While pegylation of 
CPMV completely eliminated background binding 
of the virus to tumor cells, the folate moiety allowed 
CPMV-specifi c recognition of tumor cells bearing the 
folate receptor [87]. 
2. Development of functional materials 
based on non-covalent interactions
The intrinsic chemistry of BNPs extends their 
applications far beyond the basic covalent annealing 
of different functional groups on the surface. Non-
covalent interactions (i.e., metal ligand, lectin
sugar, charge charge, π π stacking, and many other 
interactions) have emerged as excellent approaches 
for introducing novel functionalities to into BNPs. 
BNP-based inorganic materials, greatly advanced 
over the past years by Mann, Douglas, Young, and 
Belcher, have made important contributions to the 
synthesis of inorganic nanoparticles [32, 88 91]. 
Highly uniform, water-soluble protein shells provide 
the added benefits of preventing aggregation and 
sequestering mineralization reactions with various 
metallic ions [92 94]. 
TMV, a rod-like BNP with a length of 300 nm 
and 18 nm in diameter, which can be purified from 
infected tobacco plants in large quantities, has been 
exploited as template to grow metal or metal oxide 
nanoparticles such as iron oxyhydroxides, CdS, 
PbS, gold, nickel, cobalt, silver, copper, iron oxides, 
CoPt, FePt3, and silica [95 102]. From electrophoretic 
measurements, the isoelectric point of TMV is around 
3.4 and so at neutral pH, the TMV surface has net 
negative charge. In order to achieve successful 
coating based on the electrostatic interactions, the 
deposition conditions should be varied in order to 
match the interaction between the virion surface 
and the deposition precursor. In the case of silica 
coating, carrying out the reaction at pH<3 results 
in a positively charged TMV surface that will have 
strong interactions with the anionic silicate sols 
formed by hydrolysis of tetraethyl orthosilicate 
(TEOS). In contrast, CdS, PbS, and iron oxides can 
be successfully coated on the outer surface at near 
neutral pH by specific metal ion binding with the 
glutamate and aspartate residues [96]. As for metal 
deposition, in some cases, a suitable activation agent 
is needed in order to realize successful coating [101]. 
Pd(II) and Pt(II) are two typical activation agents. 
The metal deposition can occur either inside the 
inner channel or at the outer surface of TMV [101]. 
Genetically engineered TMV can show enhanced 
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deposition of metal onto its surface [24, 103]. In this 
case, native TMV was genetically altered to display 
multiple metal binding sites through the insertion 
of two cysteine residues within the amino-terminus 
of the virus coat protein. In situ chemical reductions 
successfully deposited silver, gold, and palladium 
clusters coating onto the genetically modified TMV 
without any activation agent [103]. Furthermore, 
mixing TMV with aniline and a mild oxidant 
resulted in highly uniform, micron length nanofi bers 
measuring approximately 22 nm in diameter, likely 
due to the non-covalent interactions between aniline 
and TMV [30]. These nanofibers were readily 
dispersed in water and addition of dopants increased 
the conductivity of the composite nanofi bers [31].
Another good example is bacteriophage M13, a 
filamentous bacteriophage that measures 800 900 
nm in length and 6 8 nm in diameter. In 1992, Brown 
pioneered the use of phage display for the screening 
and binding of inorganic materials [104]. Belcher and 
co-workers expanded this phage display technique 
to decorate M13 bacteriophage with different metal 
binding peptides specific to inorganic materials, 
such as semiconductor materials like GaAs, InP, 
ZnS, CdS, and magnetic materials like FePt, CoPt, 
Co, and Au, or composites [24, 105 107]. Nanowires, 
nanorings [108], nanofi bers [109], fi lms [106, 110], and 
other nanostructures [107, 111, 112] have also been 
engineered by displaying specific receptors at the 
pⅢ of the phage networks and other assemblies with 
predictable structures. Furthermore, nanostructures 
that  are  more complex can be  produced by 
incorporating two or more fusion proteins in the 
same mutant M13 particles. For example, both pⅧ 
and pⅢ of M13 have been engineered as templates 
to assemble Au and CdSe nanocrystal/hetero-
nanocrystal arrays and Au nanowires [113, 114]. 
These studies demonstrate that various substrate-
specific motifs can be independently selected from 
type 8 or type 3 libraries (where the genes encoded 
pⅧ and pⅢ are mutated) and then genetically 
incorporated into M13 structures to produce versatile 
hybrid materials with hetero-functionalities. Such 
bio-inorganic hybridized materials have been used to 
generate thin, fl exible lithium batteries [115]. 
Douglas and Young used CCMV, a spherical virus 
composed of 180 identical 20-kDa protein subunits, 
as a nano-sized reactor to develop hybrid inorganic 
materials. Since the inner surface of each protein 
subunit of CCMV presents nine basic residues 
(arginine and lysine) and creates a highly positively 
charged interior, a wide variety of negatively charged 
polyoxometalate species (vanadate, molybdate, and 
tungstate) were selectively mineralized at pH=5 
within empty CCMV particles devoid of the nucleic 
acid; the size of the capsid cavity defines the size 
of mineralized particles (Fig. 8(a)) [88]. Similarly, a 
genetically engineered mutant CCMV particle with 
a negatively charged interior (the nine basic residues 
at the N-terminus of CCMV were replaced with 
glutamic acid) was used to sequester a nanoparticle 
of iron oxide through spatially constrained oxidative 
Figure 8    Schematic illustration of two different strategies to prepare hybrid inorganic/viral core-shell particles: (A) using a void viral capsid as 
reaction vector to synthesize an inorganic core; (B) using different inorganic particles to nucleate the assembly of coat proteins
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hydrolysis of Fe (Ⅱ) [91]. This strategy has also been 
employed to encapsulate horseradish peroxidase 
enzymes, where a single enzyme reactor was 
constructed and the activities were studied at the 
single-molecule level [116, 117].
To synthesize hybrid inorganic/viral core-shell 
particles, it was demonstrated that inorganic particles 
could serve as a core to nucleate the assembly of viral 
capsids (Fig. 8(b)). For example, Dragnea and co-
workers used gold nanoparticles, quantum dots, and 
magnetic nanoparticles to induce the organization of 
the coat proteins of brome mosaic virus (BMV) [118
121]. Therefore, nanoparticles can be encapsulated by 
self-assembly in viral capsids, yielding VLPs in size 
similar to the native virus. Furthermore, manipulation 
of the diameter of the packaged material can be used 
to vary the degree of packaging. Another strategy of 
packaging nanoparticles in viral capsids was reported 
by Franzen, where the origin of assembly sequences 
was used as a trigger to package nanoparticles [122]. 
Association of these sequences on nanoparticles 
provides recognition to the coat protein of wild-type 
red clover necrotic mosaic virus (RCNMV), and self-
assembly of coat protein then begins until a VLP is 
formed with the nanoparticles fully packaged within 
the coat protein. The specifi c non-covalent interaction 
between the RCNMV coat protein and the sequences 
tethered on the nanoparticles offers great stability and 
specificity in encapsidation of nanoparticles that can 
be further explored for packaging other cargos [123]. 
In another study, virus-modified particles were 
fabricated by the layer-by-layer approach and fused 
with rubella virus-like particles (RVLPs) [124, 125]. 
Hence, it may be possible to fabricate particles 
with virus functions at the surface of colloidal 
particles along with other biological properties on 
the nano/micro meter scale. It can be concluded 
that non-covalent interactions, including layer-by-
layer techniques, may be a general approach for the 
transfer of biological functionalities of various kinds 
of viruses onto colloids, capsules, and flat surfaces 
[126 129].
3. Discussion
The major features of BNPs that have been exploited 
to generate novel biotemplates in the nanometer 
range have been highlighted throughout the paper. 
In short, their superb symmetry and size uniformity, 
and system modularity in combination with genetic 
engineering place BNPs as a material distinct from 
polymeric materials. Viruses, ferritins, enzyme 
complexes, chaperonines, and carboxysomes can 
range widely in shape and size (spherical, rod-like, 
from tens to hundreds of nanometers) with diverse 
chemical and physical properties, thereby presenting 
an extensive selection of primary building blocks. 
Since these characterized BNPs only represent a 
small fraction of the entire biodiversity, investigation 
of other BNPs and their unique properties would be 
of particular interest. For instance, viruses isolated 
from extreme environments (e.g., high temperature) 
would likely possess unparalleled thermal stabilities 
which could allow for additional chemical reactions 
at temperatures that would normally destroy other 
BNP templates. Comparative analysis amongst other 
BNPs may also elucidate which structural features 
sequences would tolerate chemical and genetic 
modifi cations, large peptide insertions, and structural 
integrity. 
Numerous studies have demonstrated the 
potential of BNPs in biomedical applications made 
possible by attaching ligands and small molecules to 
redirect the protein carriers to different cell types for 
drug/gene delivery and cell imaging. The nanosized 
probes can further be modified with chemical 
compounds, such as bio-imaging agents (near 
infrared fl uorescent dyes, magnetic contrast imaging 
agents) and drugs at high local concentrations 
to increase detection sensitivity and efficacy in 
therapeutic applications. Furthermore, the BNPs can 
be modifi ed with polymers to boost their half-life in 
the host, either by shielding the protein structures 
from enzymatic degradation or the host’s immune 
response. 
Despite the advantages the BNPs possess, a 
protein-based system exhibits similar limitations to 
any other biological system. Unlike their inorganic 
nanoparticle counterparts, the biological system 
exhibits much lower stabilities at high temperatures, 
in various organic solvents, and during long-term 
storage. In addition, while these protein systems 
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possess the potential to generate libraries, only one 
type of virus (bacteriophage M13) has a tested virus-
display and screening procedure. The possibility of 
generating large arrays of mutant viruses, ferritins, 
and BNPs and screening these systems against 
specific targets is essential in order to realize the 
full potential of these BNPs. Ultimately, through 
the combination of these various functionalization 
schemes, BNPs could be designed as versatile 
templates with nanosized features for material 
synthesis  that would not be feasible via the 
traditional top-down fabrication techniques.
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